Filter

Refine by collections

  • Thyroid (43)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 43 items for :

  • "thyroid cancer" x
Clear All
Hui Li Department of Thyroid Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, P. R. China.

Search for other papers by Hui Li in
Google Scholar
PubMed Close
and
Peng Wu Department of Thyroid Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, P. R. China.

Search for other papers by Peng Wu in
Google Scholar
PubMed Close

various diseases, including thyroid cancer ( 3 , 4 ). This regulation includes DNA methylation, chromatin remodeling, histone modifications, and the expression of diverse non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long ncRNAs (lncRNAs), and

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-24-0087
Volume/Issue:
Volume 13: Issue 9
Open access
Sara Ahmadi Division of Endocrinology, Thyroid Section, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Sara Ahmadi in
Google Scholar
PubMed Close
and
Iñigo Landa Division of Endocrinology, Thyroid Section, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Iñigo Landa in
Google Scholar
PubMed Close

Introduction Thyroid cancer is the most common malignancy of the endocrine system. Papillary thyroid carcinoma (PTC) is the most common thyroid carcinoma, accounting for almost 80% of cases; 12% of thyroid carcinomas have follicular (FTC) or

Article Type:
Review Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0297
Volume/Issue:
Volume 13: Issue 2
Open access
Sara Ahmadi Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Sara Ahmadi in
Google Scholar
PubMed Close
,
Alexandra Coleman Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Alexandra Coleman in
Google Scholar
PubMed Close
,
Nathalie Silva de Morais Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA
Endocrinology Service, Instituto Nacional de Câncer, Rio de Janeiro, Brazil

Search for other papers by Nathalie Silva de Morais in
Google Scholar
PubMed Close
,
Iñigo Landa Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Iñigo Landa in
Google Scholar
PubMed Close
,
Theodora Pappa Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Theodora Pappa in
Google Scholar
PubMed Close
,
Alex Kang Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Alex Kang in
Google Scholar
PubMed Close
,
Matthew I Kim Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Matthew I Kim in
Google Scholar
PubMed Close
,
Ellen Marqusee Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Ellen Marqusee in
Google Scholar
PubMed Close
, and
Erik K Alexander Thyroid Section Brigham & Women’s Hospital & Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Erik K Alexander in
Google Scholar
PubMed Close

Introduction The past two decades have witnessed a dramatic rise in the incidence of newly diagnosed thyroid cancer ( 1 ), primarily attributable to the detection of incidental or small-volume disease. Simultaneous to this, practitioners have

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-21-0371
Volume/Issue:
Volume 11: Issue 5
Open access
Zherui Fu Department of Emergency, The First People’s Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China

Search for other papers by Zherui Fu in
Google Scholar
PubMed Close
,
Yi Lai Department of Emergency, The First People’s Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China

Search for other papers by Yi Lai in
Google Scholar
PubMed Close
,
Qianfei Wang Department of Emergency, The First People’s Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China

Search for other papers by Qianfei Wang in
Google Scholar
PubMed Close
,
Feng Lin Department of Orthopedics, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China

Search for other papers by Feng Lin in
Google Scholar
PubMed Close
, and
Jiaping Fang Department of Emergency, The First People’s Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China

Search for other papers by Jiaping Fang in
Google Scholar
PubMed Close

Introduction Thyroid cancer is one of the most common malignant tumors of the endocrine system, accounting for 2% of all malignant tumors. The incidence of thyroid cancer has rapidly increased in recent decades, which is a significant concern

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0418
Volume/Issue:
Volume 13: Issue 1
Open access
Yanling Cai Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

Search for other papers by Yanling Cai in
Google Scholar
PubMed Close
,
Yan Yang Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

Search for other papers by Yan Yang in
Google Scholar
PubMed Close
,
Xiao Pang Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

Search for other papers by Xiao Pang in
Google Scholar
PubMed Close
, and
Suping Li Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

Search for other papers by Suping Li in
Google Scholar
PubMed Close

Introduction Thyroid cancer (TC) is the most common endocrine tumor, and its global incidence is increasing annually; however, the global incidence among females is 10.1 per 100,000, which is three times higher than the incidence among males

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0299
Volume/Issue:
Volume 12: Issue 12
Open access
Kim Magaly Pabst Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany

Search for other papers by Kim Magaly Pabst in
Google Scholar
PubMed Close
,
Robert Seifert Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

Search for other papers by Robert Seifert in
Google Scholar
PubMed Close
,
Nader Hirmas Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany

Search for other papers by Nader Hirmas in
Google Scholar
PubMed Close
,
Martina Broecker-Preuss Department of Medicine, Ruhr-University Bochum, University Hospital, Knappschaftskrankenhaus Bochum, Bochum, Germany

Search for other papers by Martina Broecker-Preuss in
Google Scholar
PubMed Close
,
Manuel Weber Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany

Search for other papers by Manuel Weber in
Google Scholar
PubMed Close
,
Wolfgang Peter Fendler Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany

Search for other papers by Wolfgang Peter Fendler in
Google Scholar
PubMed Close
,
Timo Bartel Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany

Search for other papers by Timo Bartel in
Google Scholar
PubMed Close
,
Sarah Theurer German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Institute of Pathology, University Hospital Essen, University Duisburg-Essen, Essen, Germany

Search for other papers by Sarah Theurer in
Google Scholar
PubMed Close
,
Ken Herrmann Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany

Search for other papers by Ken Herrmann in
Google Scholar
PubMed Close
, and
Rainer Görges Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany

Search for other papers by Rainer Görges in
Google Scholar
PubMed Close

over a period of >10 years. Conclusion U-hsTg measurement in patients with differentiated thyroid cancer within 24 months after completing radioiodine therapy showed higher predictive power than s-Tg measurement for RFS for a time period >10

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-22-0312
Volume/Issue:
Volume 12: Issue 2
Open access
Tian Zhou School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China
Department of Breast Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

Search for other papers by Tian Zhou in
Google Scholar
PubMed Close
,
Dai-wei Zhao School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China
Department of Surgery, Second People's Hospital of Guizhou Province, Guiyang, Guizhou, China

Search for other papers by Dai-wei Zhao in
Google Scholar
PubMed Close
,
Ning Ma School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China

Search for other papers by Ning Ma in
Google Scholar
PubMed Close
,
Xue-ying Zhu School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China

Search for other papers by Xue-ying Zhu in
Google Scholar
PubMed Close
,
Xing-hong Chen Department of Surgery, Second People's Hospital of Guizhou Province, Guiyang, Guizhou, China

Search for other papers by Xing-hong Chen in
Google Scholar
PubMed Close
,
Xue Luo Department of Breast Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

Search for other papers by Xue Luo in
Google Scholar
PubMed Close
,
Song Chen School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China

Search for other papers by Song Chen in
Google Scholar
PubMed Close
, and
Qing-jun Gao Department of Thyroid Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

Search for other papers by Qing-jun Gao in
Google Scholar
PubMed Close

Introduction The incidence of thyroid cancer (THCA) ranks first among head and neck cancers ( 1 ). Thyroid cancer can be divided into four histological types: papillary thyroid carcinoma (PTC), follicular carcinoma, anaplastic carcinoma, and

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-22-0390
Volume/Issue:
Volume 12: Issue 4
Open access
Teresa Kraus Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria

Search for other papers by Teresa Kraus in
Google Scholar
PubMed Close
,
Natalia Shengelia-de Lange Division of Nuclear Medicine, Tbilisi State Medical University, Tbilisi, Georgia

Search for other papers by Natalia Shengelia-de Lange in
Google Scholar
PubMed Close
,
Holger Einspieler Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria

Search for other papers by Holger Einspieler in
Google Scholar
PubMed Close
,
Marcus Hacker Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria

Search for other papers by Marcus Hacker in
Google Scholar
PubMed Close
,
Alexander Haug Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria

Search for other papers by Alexander Haug in
Google Scholar
PubMed Close
,
Elisabeth Kretschmer-Chott Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria

Search for other papers by Elisabeth Kretschmer-Chott in
Google Scholar
PubMed Close
, and
Georgios Karanikas Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria

Search for other papers by Georgios Karanikas in
Google Scholar
PubMed Close

this article). There was no statistically significant difference between the TNM staging in patients from Vienna and Tbilisi. The distribution of histotype showed 345 patients with papillary thyroid cancer (PTC) (93%) and 25 patients with follicular

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-24-0007
Volume/Issue:
Volume 13: Issue 5
Open access
Maria Luisa Garo Mathsly Research, Roma, Italy

Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed Close
,
Désirée Deandreis Division of Nuclear Medicine, Department of Medical Sciences, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy

Search for other papers by Désirée Deandreis in
Google Scholar
PubMed Close
,
Alfredo Campennì Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy

Search for other papers by Alfredo Campennì in
Google Scholar
PubMed Close
,
Alexis Vrachimis Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus

Search for other papers by Alexis Vrachimis in
Google Scholar
PubMed Close
,
Petra Petranovic Ovcaricek Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia

Search for other papers by Petra Petranovic Ovcaricek in
Google Scholar
PubMed Close
, and
Luca Giovanella Clinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland

Search for other papers by Luca Giovanella in
Google Scholar
PubMed Close

Introduction Differentiated thyroid cancer (DTC) accounts for 90% of all thyroid cancers and is increasing threefold every decade ( 1 ) so that by 2040 it will be the fourth most common malignancy in the group aged 20–49 years ( 2 ). Papillary

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-22-0457
Volume/Issue:
Volume 12: Issue 4
Open access
Giuseppe Lisco Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Giuseppe Lisco in
Google Scholar
PubMed Close
,
Anna De Tullio Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Anna De Tullio in
Google Scholar
PubMed Close
,
Olga Disoteo Diabetology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Search for other papers by Olga Disoteo in
Google Scholar
PubMed Close
,
Giuseppina Piazzolla Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Giuseppina Piazzolla in
Google Scholar
PubMed Close
,
Edoardo Guastamacchia Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Edoardo Guastamacchia in
Google Scholar
PubMed Close
,
Carlo Sabbà Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Carlo Sabbà in
Google Scholar
PubMed Close
,
Vincenzo De Geronimo Unit of Endocrinology, Policlinico Morgagni CCD, Catania, Italy

Search for other papers by Vincenzo De Geronimo in
Google Scholar
PubMed Close
,
Enrico Papini Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Rome, Italy

Search for other papers by Enrico Papini in
Google Scholar
PubMed Close
, and
Vincenzo Triggiani Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Vincenzo Triggiani in
Google Scholar
PubMed Close

. Adequate hydration and fiber consumption, cessation of alcoholic beverage consumption, and eating lighter and smaller meals can be useful advice ( 6 ). The association between chronic exposure to GLP-1RAs and the new onset of thyroid cancer is a growing

Article Type:
Review Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0257
Volume/Issue:
Volume 12: Issue 11
Open access